p. 1817−1826
2476-762X
Vol.23/No.6
p. 1827−1835
2476-762X
Vol.23/No.6
p. 1837−1845
2476-762X
Vol.23/No.6
p. 1847−1858
2476-762X
Vol.23/No.6
p. 1859−1866
2476-762X
Vol.23/No.6
p. 1867−1872
2476-762X
Vol.23/No.6
p. 1873−1878
2476-762X
Vol.23/No.6
T Promoter Polymorphism in Patients with Colorectal Cancer in an Azerbaijani Population]]>
T polymorphism in colorectal cancer (CRC) patients. Methods: A total of 140 patients with CRC and 164 healthy individuals were included in the study. According to the manufacturer’s instructions, DNA was isolated from blood, and genotypes were determined on agarose gel by the PCR-RFLP method. Genotype confirmation was performed using Sanger sequencing in randomly selected samples. Results: When comparing the case and control groups, heterozygous GT (OR=0.53; 95% CI=0.32–0.88), under the dominant model (OR=0.53; 95% CI=0.33–0.87), and the mutant T allele (OR=0.71; 95% CI=0.51–0.98) were statistically associated with a reduced risk of CRC. However, when the age, pathological tumor grade and stage, smoking habit, and alcohol consumption were compared, no significant relationship was determined (P>0.05). Furthermore, among males, heterozygous GT was associated with a reduced risk of CRC (OR=0.40; 95% CI=0.19–0.84). Conclusion: Our study highlighted that the –579 G>T polymorphism of the DNMT3B gene plays a protective role against CRC development.]]>
p. 1879−1884
2476-762X
Vol.23/No.6
p. 1885−1891
2476-762X
Vol.23/No.6
p. 1893−1900
2476-762X
Vol.23/No.6
p. 1901−1911
2476-762X
Vol.23/No.6
p. 1913−1920
2476-762X
Vol.23/No.6
p. 1921−1926
2476-762X
Vol.23/No.6
p. 1927−1933
2476-762X
Vol.23/No.6
p. 1935−1944
2476-762X
Vol.23/No.6
p. 1945−1950
2476-762X
Vol.23/No.6
p. 1951−1957
2476-762X
Vol.23/No.6
p. 1959−1965
2476-762X
Vol.23/No.6
p. 1967−1973
2476-762X
Vol.23/No.6
p. 1975−1981
2476-762X
Vol.23/No.6
p. 1983−1992
2476-762X
Vol.23/No.6
p. 1993−2000
2476-762X
Vol.23/No.6
p. 2001−2008
2476-762X
Vol.23/No.6
p. 2009−2016
2476-762X
Vol.23/No.6
p. 2017−2025
2476-762X
Vol.23/No.6
p. 2027−2033
2476-762X
Vol.23/No.6
p. 2035−2047
2476-762X
Vol.23/No.6
p. 2049−2055
2476-762X
Vol.23/No.6
p. 2057−2063
2476-762X
Vol.23/No.6
p. 2065−2070
2476-762X
Vol.23/No.6
p. 2071−2077
2476-762X
Vol.23/No.6
p. 2079−2087
2476-762X
Vol.23/No.6
p. 2089−2093
2476-762X
Vol.23/No.6
p. 2095−2103
2476-762X
Vol.23/No.6
p. 2105−2111
2476-762X
Vol.23/No.6
p. 2113−2118
2476-762X
Vol.23/No.6
p. 2119−2125
2476-762X
Vol.23/No.6
p. 2127−2135
2476-762X
Vol.23/No.6
p. 2137−2143
2476-762X
Vol.23/No.6
p. 2145−2150
2476-762X
Vol.23/No.6
p. 2151−2158
2476-762X
Vol.23/No.6
p. 2159−2167
2476-762X
Vol.23/No.6
p. 2169−2176
2476-762X
Vol.23/No.6